The Motley Fool Market update
News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 1–36
- Matches
- 151
- Sources here
- 13
- Companies here
- 3
Active search
151 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Zacks Research Downgrades Monopar Therapeutics (NASDAQ:MNPR) to Hold
Zacks Research downgraded Monopar Therapeutics (NASDAQ:MNPR) from a "strong-buy" to a "hold" rating, despite the broader analyst consensus remaining a "moderate buy" with an average price target of $117.42. The company's shares opened at $113.04, trading near their 12-month high, and it recently reported …
Monolithic Power Systems, Inc. $MPWR Shares Purchased by Kornitzer Capital Management Inc. KS
Kornitzer Capital Management Inc. KS increased its stake in Monolithic Power Systems (NASDAQ:MPWR) by 19.9% in the second quarter, bringing its total holdings to 5,010 shares valued at $6,926,000. Other institutional investors also adjusted their positions in the semiconductor company. Wall Street analysts have …
State of Michigan Retirement System Sells 1,159 Shares of Monolithic Power Systems, Inc. $MPWR
The State of Michigan Retirement System decreased its stake in Monolithic Power Systems (NASDAQ:MPWR) by 8.3% in the second quarter, selling 1,159 shares and retaining 12,811 shares valued at $17.71 million. Several other institutional investors also adjusted their positions in MPWR. Analyst ratings for …
Monolithic Power Systems, Inc. $MPWR Shares Purchased by Daiwa Securities Group Inc.
Daiwa Securities Group Inc. increased its stake in Monolithic Power Systems (NASDAQ:MPWR) by 15.2% in the second quarter, bringing its total holdings to 17,286 shares valued at approximately $23.9 million. The semiconductor company reported strong Q2 earnings, beating analyst estimates with an EPS of …
Monolithic Power Systems and Las Vegas Sands have been highlighted as Zacks Bull and Bear of the Day
Zacks Equity Research has named Monolithic Power Systems (MPWR) as its Bull of the Day due to strong earnings, significant growth in AI-related power management solutions, and a Zacks Rank #1 (Strong Buy). Conversely, Las Vegas Sands (LVS) is designated as the Bear of …
Bull of the Day: Monolithic Power Systems (MPWR)
Monolithic Power Systems MPWR designs, develops, and markets high-performance power solutions. The company focuses on the market for high-performance analog and mixed-signal integrated circuits (ICs). Its products are widely used in industrial applications, telecommunications infrastructure, cloud computing, and automotive and consumer applications. The stock …
Monolithic Power Systems director Herbert Chang sells $71,000 in stock
Monolithic Power Systems director Herbert Chang sold 50 shares of company stock for $71,000 on August 11, 2026, reducing his direct beneficial ownership to 565 shares. Despite the stock appearing overvalued according to InvestingPro, analysts project a 34% upside potential, with price targets ranging …
Monopar Therapeutics Shares Drop After Downgrade From Cantor Fitzgerald
Monopar Therapeutics' shares dropped following a downgrade from Cantor Fitzgerald, which revised its rating from Overweight to Neutral and adjusted the price target from $109 to $119. This news comes amidst other recent developments for the company, including its Q2 earnings report and FDA …
Monopar downgraded to Neutral at Cantor (MNPR:NASDAQ)
Monopar Therapeutics Inc. (MNPR) was downgraded to Neutral from Overweight by Cantor Fitzgerald after a significant rally in its stock price. Cantor Fitzgerald believes the clinical-stage biopharma is now fairly valued following a nearly 90% increase over the past six months. This downgrade led …
If You Invested $1000 in Monolithic Power 10 Years Ago, This Is How Much You'd Have Now
An investment of $1000 in Monolithic Power (MPWR) ten years ago would now be worth $19,374.71, representing an 1,837.47% gain, significantly outperforming the S&P 500 and gold during the same period. The company, which designs high-performance power solutions, reported strong Q2 2026 revenues and …
Sharemaestro market context Trend signal active 52 weeks +55.1% · Next-week setup negative 26.5%Monopar Therapeutics Releases Q2 2026 Financial Results
Monopar Therapeutics Inc. reported a widening net loss of $5.3M, or $0.62 per share, for Q2 2026, compared to a loss of $0.35 per share in the prior year. This increase in losses is attributed to the capital-intensive nature of advancing its cancer treatment …